Synonym
KNI 10033; KNI10033; KNI-10033
IUPAC/Chemical Name
N-((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)-3-((2S,3S)-2-hydroxy-3-(2-(2-(isoquinolin-5-yloxy)acetamido)-3-(methylthio)propanamido)-3-phenylpropanoyl)-5,5-dimethylthiazolidine-4-carboxamide
InChi Key
PWVMVWOCCXBXAM-SDAKZCOPSA-N
InChi Code
InChI=1S/C39H43N5O7S2/c1-39(2)35(37(49)43-33-27-14-8-7-12-24(27)18-29(33)45)44(22-53-39)38(50)34(47)32(23-10-5-4-6-11-23)42-36(48)28(21-52-3)41-31(46)20-51-30-15-9-13-25-19-40-17-16-26(25)30/h4-17,19,28-29,32-35,45,47H,18,20-22H2,1-3H3,(H,41,46)(H,42,48)(H,43,49)/t28?,29-,32+,33+,34+,35?/m1/s1
SMILES Code
CSCC(C(N[C@@H](c1ccccc1)[C@@H](C(N2CSC(C)(C2C(N[C@@H]3[C@@H](Cc4c3cccc4)O)=O)C)=O)O)=O)NC(COc(ccc5)c6c5cncc6)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
757.92
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Kar P, Lipowsky R, Knecht V. Importance of polar solvation and configurational entropy for design of antiretroviral drugs targeting HIV-1 protease. J Phys Chem B. 2013 May 16;117(19):5793-805. doi: 10.1021/jp3085292. Epub 2013 May 8. PMID: 23614718.
2: Lafont V, Armstrong AA, Ohtaka H, Kiso Y, Mario Amzel L, Freire E. Compensating enthalpic and entropic changes hinder binding affinity optimization. Chem Biol Drug Des. 2007 Jun;69(6):413-22. doi: 10.1111/j.1747-0285.2007.00519.x. PMID: 17581235.
3: Mishra V, Rathore I, Arekar A, Sthanam LK, Xiao H, Kiso Y, Sen S, Patankar S, Gustchina A, Hidaka K, Wlodawer A, Yada RY, Bhaumik P. Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights. FEBS J. 2018 Aug;285(16):3077-3096. doi: 10.1111/febs.14598. Epub 2018 Jul 7. PMID: 29943906; PMCID: PMC6309945.
4: Yoshida T, Hayashi T, Mashima A, Chuman H. A simple and efficient dispersion correction to the Hartree-Fock theory (2): Incorporation of a geometrical correction for the basis set superposition error. Bioorg Med Chem Lett. 2015 Oct 1;25(19):4179-84. doi: 10.1016/j.bmcl.2015.08.008. Epub 2015 Aug 7. PMID: 26292629.